Anticancer effects of prebiotics synergyl® and soybean extracts: Possible synergistic mechanisms in caco-2 cells

International Journal of Cancer Research

Volumn 6, Issue 4, 2010, Pages 220-233

  Gourineni, V P ^a   Verghese, M ^a   Boateng, J ^a  

^a ALABAMA A AND M UNIVERSITY   (United States)

Author keywords

Chemoprevention; Colon cancer; Dietary fiber; Isoflavones; Synergism

Indexed keywords

BUTYRIC ACID; CASPASE 3; DAIDZEIN; EQUOL; GENISTEIN; GLUTATHIONE TRANSFERASE; GLYCITEIN; HISTONE; LACTATE DEHYDROGENASE; OLIGONUCLEOTIDE; PLANT MEDICINAL PRODUCT; PREBIOTIC AGENT; SYNERGY1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL LYSATE; CELL STRAIN CACO 2; CELL STRUCTURE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; PHYTOCHEMISTRY; PHYTONUTRIENT; PROTEIN FUNCTION; SOYBEAN;

EID: 78149446284     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2010.220.233     Document Type: Article

References (39)

1. ACS., 2009. The Colon and Rectum Cancer Resource. American Cancer Society, Kansas.
2. Aherne, S.A., J.P. Kerry and N.M. OBrien, 2007. Effects of plant extracts on antioxidant status and oxidant induced stress in Caco-2 cells. Br. J. Nutr., 97: 321-328.
3. Archer, S.Y., J. Johnson, H.J. Kim, Q. Ma and H. Mou et al, 2005. The histone deacetylase inhibitor butyrate downregulates cyclin Bl gene expression via p21 AVAF-1 dependent mechanism in human colon cancer cells. Am. J. Physiol. Gastrointest Liver Physiol., 289: G696-703.
4. Avivi-Green, C, S. Polak-Charcon, Z. Madar and B. Schwartz, 2002. Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J. Nutr., 132: 1812-1818.
5. Beyer-Sehlmeyer, G., M. Glei, E. Hartmann, R. Hughes, C. Persin and V. Böhm et al, 2003. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br. J. Nutr., 90: 1057-1070.
6. Blay, M., A.E. Espmel, M.A. Delgado, I. Baiges, C. Blade, L. Arola and J. Salvado, 2010. Isoflavone effect on gene expression profile and biomark ers of inflammation. J. Pharma Biomed. Anal., 51: 382-390.
7. Boateng, J., M. Verghese, L.T. Walker, L. Shackelford and C.B. Chawan, 2008. Antitumor and cytotoxic properties of dry beans (Phaseolus sp. L.): An in vitro and in vivo model. Int. J. Cancer Res., 4: 41-51.
8. Chen, Y., C. Huang, T. Zhoua and G. Chen, 2008. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin. Pharmacol. Toxicol.103: 553-559.
9. De Kok, T.M., S.G. Van Beda and M.M. Manson, 2008. Mechanisms of combined action of different chemopreventive dietary compounds: A review. Eur. J. Nutr., 47: 51-59.
10. Dong, M., X. He and R.H. Liu, 2007. Phytochemicals of black bean seed coats: isolation, structure elucidation and their antiproliferative and antoxidant activities. J. Agric. Food Chem.,55: 6044-6051.
11. Duessel, S., R.M. Heuertz and U.R. Ezekiel, 2008. Growth inhibition of human colon cancer cells by plant compounds. Clin. Lab. Sei., 21: 151-157.
12. Gerber, M., 2001. The comprehensive approach to diet: A critical review. J. Nutr., 131: 3051S-3055S.
13. Guo, J.M., B.X. Xiao, D.H. Liu, M. Grant and S. Zhang et al, 2004. Biphasic effect of daidzein on cell growth of human colon cancer cells. FoodChem. Toxicol., 42: 1641-1646.
14. Habig, W.H., M.J. Pabst and W.B. Jakoby, 1974. Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139.
15. Jacobs, D.R. and L.M. Steffen, 2003. Nutrients, foods and dietary patterns as exposures in research: A framework for food synergy. Am. J. Clin. Nutr., 78: 508S-513S.
16. Kuo, S.M., 1996. Antiproliferative potency of structurally distinct dietary flavanoids L-against D-galactosamine and carbon tetra chloride on in situ perfused in liver. Ind. J. Physiol. Pharmacol., 45: 41-48.
17. Lim, C.C., L.R. Ferguson and G. W. Tannock, 2005. Dietary fibres as prebiotics: Implications for colorectal cancer. Mol. Nutr. FoodRes., 49: 609-619.
18. Liu, R.H., 2003. Health benefits of fruits and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr., 78: 517S-520S.
19. Liu, R.H., 2004. Potential synergy of phytochemicals in cancer prevention: Mechanism of action. J. Nutr., 134: 3479S-3485S.
20. MacDonald, R.S., J. Guo, J. Copeland, Jr. J.D. Browning, D. Sleper, G.E. Rottinghaus and M.A. Berhow, 2005. Environmental influences on isoflavones and saponins in soybeans and their role in colon cancer. J. Nutr., 135: 1239-1342.
21. Messina, M. and M. Bennink, 1998. Soyfoods, isoflavones and risk of colonic cancer: A review of the in vitro and in vivo data. Clin. Endocrinol. Metab., 4: 707-728.
22. Messina, M.J., 1999. Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin Nutr., 70: 439S-450S.
23. Messina, M. J., V. Persky, K.D.R. Setchell and S. Barnes, 1994. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer, 21:113-131.
24. Munjal, U., M. Glei, B.L. Pool-Zobel and D. Scharlau, 2009. Fermentation products of Inulin type fructans reduce proliferation and induce apoptosis in human colon tumor cells of different stages of carcinogenesis. Br. J. Nutr., 102: 663-671.
25. Omoni, A.O. and R.E. Aluko, 2005. Soybean foods and their benefits: Potential mechanisms of action. Nutr. Rev., 63: 272-283.
26. Potter, J.D., 1993. Colon cancer-do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story?. J. Nutr., 123: 418-423.
27. Putman, S.E., A.M. Scutt, K. Bicknell, CM. Priestley and E.M. Williamson, 2007. Natural products as alternate treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res., 21: 99-112.
28. Radzikowski, C, J. Wietrzyk, G. Grynkiewicz and A. Opolski, 2004. Genistein: A soy isoflavone revealing a pleiotropic mechanism of action-clinical implications in the treatment and prevention of cancer. Postepy Hig. Med. Dosw, 58: 128-139.
29. SAS., 2007. Statistical Analysis Software. SAS Institute Inc., Cary, NC.
30. Spector, D., M. Anthony, D. Alexander and L. Arab, 2003. Soy consumption and colorectal cancer. Nutr. Cancer, 47: 1-12.
31. Subhashinee, S., K. Wijeratne and S.L. Cuppett, 2007. Soy isoflavones protect the intestine from lipid hydroperoxide mediated oxidative damage. J. Agric. Food Chem., 55: 9811-9816.
32. Verghese, M., D.R. Rao, C.B. Chawan, L.L. Williams and L. Shackelford, 2002. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young fisher 344 rats. J. Nutr., 132: 2809-2813.
33. Verghese, M., D.R. Rao, C.B. Chawan, L.T. Walker and L. Shackelford, 2006. Anticarcinogenic effect of phytic acid (IP 6) Apoptosis as a possible mechanism of action. LWT-FoodSci. Technol, 39: 1093-1098.
34. WHO., 2009. Statistics of all Cancer Mortalities m the World by 2030. World Health Organization, Rome, Italy.
35. Willet, W.C., 1995. Diet, nutrition and avoidable cancer. Environ. Health Prospect, 103: 165-170.
36. Yang, K.M., J.O. Pvo, G.Y. Kim, R. Yu and l.S. Haneïa., 2009. Capsaicin induces apoptosis by generating recative oxygen species and disrupting mitochondrial transmembrane potential in human colon cancer cell lines. Cell Mol. Biol. Lett, 14: 497-510.
37. Yu, Z., Y. Tang, D. Hu and J. Li, 2005. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-betal/Smad pathway. Biochem. Biophys Res. Commun., 333: 827-832.
38. Zessner, H., L. Pan, F. Will, K. Klimo and J. Knauft et al., 2008. Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential. Mol. Nutr. Food Res., 52: S28-44.
39. Zhu, Q., J. Meisinger, D.H. Van Thiel, Y. Zhang and S. Mobarhan, 2002. Effects of Soybean extract on morphology and survival of Caco-2, SW620 and HT-29 cells. Nutr. Cancer, 42: 131-140.